Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerabililty of RVT-501 Topical Ointment in Pediatric Patients With Mild to Moderate Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Lotamilast (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Dermavant Sciences
- 18 Jul 2018 Status changed from active, no longer recruiting to completed.
- 04 May 2018 Status changed from recruiting to active, no longer recruiting.
- 15 Feb 2018 Status changed from not yet recruiting to recruiting.